Truveta launched a care insights solution for pharmaceutical and medical device companies that tracks how drugs, devices and guidelines are used in clinical practice, using daily updated deidentified EHR data and deidentified clinical notes. It includes Truveta Intelligence, the AI tool that answers natural language questions about treatment uptake, switching and discontinuation, plus dashboards and a clinical note viewer. Truveta states the solution is available to pharma and device companies now.
Our readLife sciences commercial and medical affairs teams get a packaged way to monitor launch uptake and reasons for stopping or switching therapy within days rather than waiting on billing derived data. It extends Truveta's EHR data platform from outcomes research into commercial and medical affairs use.